These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16015553)
1. Docetaxel in the treatment of esophageal cancer. Rigas JR; Dragnev KH; Bubis JA Semin Oncol; 2005 Apr; 32(2 Suppl 4):S39-51. PubMed ID: 16015553 [TBL] [Abstract][Full Text] [Related]
2. Experience with docetaxel in the treatment of gastric cancer. Philip PA Semin Oncol; 2005 Apr; 32(2 Suppl 4):S24-38. PubMed ID: 16015552 [TBL] [Abstract][Full Text] [Related]
3. Docetaxel in the management of advanced pancreatic cancer. Lopes G; Rocha Lima CM Semin Oncol; 2005 Apr; 32(2 Suppl 4):S10-23. PubMed ID: 16015551 [TBL] [Abstract][Full Text] [Related]
4. [The update on pancreatic cancer chemotherapy]. Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647 [TBL] [Abstract][Full Text] [Related]
5. [Gemcitabine-based combinations in inoperable pancreatic cancers]. Louvet C; André T; Artru P Bull Cancer; 2002 Aug; 89 Spec No():S96-101. PubMed ID: 12449038 [TBL] [Abstract][Full Text] [Related]
6. [Combined treatment of esophageal cancer: a review]. Cesas A; Bagajevas A Medicina (Kaunas); 2004; 40 Suppl 1():161-5. PubMed ID: 15079129 [TBL] [Abstract][Full Text] [Related]
7. [Progress in chemotherapy for advanced gastric cancer]. Xu RH; Teng KY Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823 [TBL] [Abstract][Full Text] [Related]
8. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials. Heinemann V Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228 [TBL] [Abstract][Full Text] [Related]
9. [Progress in therapy for testicular tumors]. Mizutani Y; Nakamura T; Nomoto T; Kawauchi A; Miki T Gan To Kagaku Ryoho; 2006 Feb; 33(2):183-7. PubMed ID: 16484853 [TBL] [Abstract][Full Text] [Related]
10. Gemcitabine: progress in the treatment of pancreatic cancer. Heinemann V Oncology; 2001; 60(1):8-18. PubMed ID: 11150902 [TBL] [Abstract][Full Text] [Related]
12. Current and ongoing trials with irinotecan in the United States. Fuchs CS Semin Oncol; 2003 Aug; 30(4 Suppl 12):9-17. PubMed ID: 14508722 [No Abstract] [Full Text] [Related]
13. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer. Green MR Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine. Schultheis B; Riebeling J; Allali M; Bergmann U; Kummer G; Sendler U; Tannapfel A; Sendler A; Strumberg D Int J Clin Pharmacol Ther; 2010 Jul; 48(7):451-2. PubMed ID: 20557841 [No Abstract] [Full Text] [Related]
15. Future treatment options with capecitabine in solid tumours. Wilke H Eur J Cancer; 2002 Feb; 38 Suppl 2():21-5. PubMed ID: 11841932 [TBL] [Abstract][Full Text] [Related]
16. Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trial. Miles D; Vukelja S; Moiseyenko V; Cervantes G; Mauriac L; Van Hazel G; Liu WY; Ayoub JP; O'Shaughnessy JA Clin Breast Cancer; 2004 Oct; 5(4):273-8. PubMed ID: 15507172 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel. Ajani JA Expert Opin Pharmacother; 2006 Aug; 7(12):1627-31. PubMed ID: 16872265 [TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC. Rocha Lima CM; Rizvi NA; Zhang C; Herndon JE; Crawford J; Govindan R; King GW; Green MR; Ann Oncol; 2004 Mar; 15(3):410-8. PubMed ID: 14998842 [TBL] [Abstract][Full Text] [Related]
19. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. Cinieri S; Chan A; Altundag K; Vandebroek A; Tubiana-Mathieu N; Barnadas A; Dodyk P; Lazzarelli S; Botha M; Rauch D; Villanova G; Coskun U Clin Breast Cancer; 2017 Apr; 17(2):91-99.e1. PubMed ID: 27756583 [TBL] [Abstract][Full Text] [Related]
20. [From ASCO and WCLC 2005 to clinical practice: "conventional" treatments]. Fournel P Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S25-9. PubMed ID: 16719153 [No Abstract] [Full Text] [Related] [Next] [New Search]